Inspection Record

Boothwyn Pharmacy LLC — FDA 483 Findings

US FDAInspected 2021-09-08Published 2024-02-29 9 findingsAseptic processing and sterility assuranceTraining and personnelEquipment and facilityValidation and qualificationContamination control

Inspectors Sena G Dissmeyer · Tanya R SyffrardThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

The use of sporicidal agents in the cleanrooms and ISO 5 classified aseptic processing area was inadequate.

2Aseptic processing and sterility assurance

Your media fills were not performed under the most challenging or stressful conditions.

3Aseptic processing and sterility assurance

Equipment was and Materials or supplies were not disinfected prior to entering the aseptic processing areas.

4Training and personnel

Personnel sampling was conducted after gloves had been cleaned/disinfected.

5Equipment and facility

Your facility failed to confirm that the quality of water was suitable for its intended use in the production of non-sterile drug products.

6Validation and qualification

1SO-5 classified areas were not certified under dynamic conditions.

7Aseptic processing and sterility assurance

Personnel conducted aseptic manipulations and placed equipment/supplies in an area that blocked the movement of first pass air around an open unit, either before or after it was filled with sterile product.

8Contamination control

You produced hazardous drugs without providing adequate containment, segregation, cleaning of work smfaces, cleaning of utensils and cleaning ofpersonnel to prevent cross-contamination.

9Aseptic processing and sterility assurance

The ISO 5 classified aseptic processing areas had difficult to clean, particle-generating and visibly dirty equipment or surface.

About this record

Extracted automatically from the document US FDA published on 2024-02-29. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Boothwyn Pharmacy LLC findings history — including this company's other documents US FDA documents, 2024 Go to Findings search